Atlas Trials

Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use.

Clinical trial NCT01983267 · COMPLETED

Trial details

NCT number
NCT01983267
Sponsor
Rambam Health Care Campus
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
1- Cancer Patients During Chemotherapy Treatment2- Use of Cannabis Comparing to Control Without Cannabis Use
Start date
2013-11-01
Primary completion
2017-04-26
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.